Lumigan Solution/ Drops
Product Images NDC 0023-3205

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lumigan (NDC 0023-3205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lumigan 01 01

Chemical structure diagram of bimatoprost, the active ingredient in LUMIGAN ophthalmic solution 0.1 mg/mL by Allergan, Inc. The diagram shows the molecular arrangement including rings, hydroxyl groups, and other chemical bonds.*

FDA Label Image

Lumigan 01 02

FDA Label Image

Lumigan 01 03

Packaging label for LUMIGAN (bimatoprost ophthalmic solution) 0.01% in a 5 mL bottle. The label displays the Allergan, Inc. brand and includes dosage and storage instructions, preservative and inactive ingredients list, barcodes, and manufacturing information. It specifies the product is sterile, prescription-only, and made in the U.S.A.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.